Vasculitis
Benjamin Terrier, MD, PhD
Cochin Hospital
Paris, France
Disclosure(s): AstraZeneca: Consultant (Ongoing), Grant/Research Support (Ongoing); Boehinger Ingelheim: Consultant (Ongoing); Bristol-Myers Squibb(BMS): Grant/Research Support (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); GlaxoSmithKline: Consultant (Ongoing), Grant/Research Support (Ongoing); LFB: Grant/Research Support (Ongoing); Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Roche: Coinvestigator of academic studies for which rituximab was provided by Roche Pharma (Ongoing); Vifor Pharma: Consultant (Ongoing)
Cristina Ponte, MD, PhD
Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte
Lisbon, Portugal
Disclosure information not submitted.
.png "Peter Merkel, MD, MPH photo")
Peter Merkel, MD, MPH
University of Pennsylvania
Philadelphia, PA, United States
Disclosure(s): AbbVie: Consultant (Ongoing), Grant/Research Support (Ongoing); AstraZeneca: Consultant (Ongoing), Grant/Research Support (Ongoing); Boeringher-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb: Consultant (Ongoing), Grant/Research Support (Ongoing); ChemoCentryx: Consultant (Ongoing), Grant/Research Support (Ongoing); CSL Behring: Consultant (Ongoing); Dynacure: Consultant (Ongoing); Eicos: Grant/Research Support (Ongoing); Electra: Grant/Research Support (Ongoing); EMDSerono: Consultant (Terminated, December 31, 2021); Forbius: Consultant (Terminated, December 31, 2021), Grant/Research Support (Terminated, December 31, 2021); Genentech/Roche: Consultant (Terminated, December 31, 2021), Grant/Research Support (Terminated, December 31, 2021); Genzyme/Sanofi: Consultant (Terminated, December 31, 2021), Grant/Research Support (Terminated, December 31, 2021); GlaxoSmithKline: Consultant (Ongoing), Grant/Research Support (Ongoing); Immagene: Consultant (Ongoing); InflaRx: Consultant (Ongoing), Grant/Research Support (Ongoing); Jannsen: Consultant (Ongoing); Kiniksa: Consultant (Terminated, July 31, 2020); Kyverna: Consultant (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Magenta: Consultant (Ongoing); Neutrolis: Consultant (Ongoing), Grant/Research Support (Ongoing); Novartis: Consultant (Ongoing); Pfizer: Consultant (Ongoing); Q32: Consultant (Ongoing); Regeneron: Consultant (Ongoing); Sparrow: Consultant (Ongoing); Takeda: Consultant (Ongoing), Grant/Research Support (Ongoing); UpToDate: Royalties (Ongoing)
Subhashis Banerjee, MD
Bristol Myers Squibb
Princeton, NJ, United States
Disclosure information not submitted.
Digest of the ACR Convergence abstracts on ANCA-associated vasculitis (AAV) and other small-vessel vasculitides
- Highlight of the most interesting research / important and emerging themes
- Comment on what to expect in the ACR Convergence sessions related to small-vessel vasculitis
- Generate discussion, including directly with some of the lead investigators on the highlighted abstracts, including for both oral presentations and posters
